425
Participants
Start Date
November 5, 2018
Primary Completion Date
March 5, 2020
Study Completion Date
January 25, 2021
MT10109L
MT10109L will be injected into either the LCL, or both the LCL and GL.
Placebo
Placebo will be injected into either the GL, or both the LCL and GL.
Dermatology and Laser Surgery Center of New York, New York
Skin Search of Rochester Inc., Rochester
Wilmington Dermatology Center, Wilmington
CentroDerm GmbH, Wuppertal
Aventiv Research Inc., Dublin
Hautzentrum Koln - Cologne Dermatology, Cologne
MediCorium Zentrum fuer Dermatologie und Aesthetik, Oberursel
Rosenpark Research, Darmstadt
DermResearch Inc., Austin
Hautok and Hautok-cosmetics, München
Clear Dermatology & Aesthetics Center, Scottsdale
Art of Skin MD, Solana Beach
Susan H. Weinkle, MD, Bradenton
Etre Cosmetic Dermatology and Laser Center, New Orleans
M3 Wake Research Inc., Raleigh
Westlake Dermatology & Cosmetic Surgery - Westlake, Austin
Dr. Jean Carruthers Cosmetic Surgery Inc., Vancouver
Pacific Derm, Vancouver
Dermetics Cosmetic Dermatology, Burlington
Nectar Research Group Inc., Richmond Hill
Medy-Tox
INDUSTRY